B

A

BERTUCCI , Alexandre

Last name: BERTUCCI

First name: Alexandre

May 20, 2021 (v1)

Journal article

Metadata-only

Alpelisib and fulvestrant efficacy in HR-positive HER2-negative PIK3CA -mutant advanced breast cancer: Data from the French early access program.

Bertucci, F. Bello, Diana Bertucci, Alexandre

1064 Background: In 11.2018, the PIK3CA-inhibitor alpelisib was made available in France through an early access program (EAP), in combination with fulvestrant in pre-treated PIK3CA-mutant, HR-positive, HER2-negative advanced breast cancer (ABC) patients. Patients had to received two or more prior systemic treatments for ABC, including an...

Uploaded on: December 3, 2022